Acute myelogenous leukemia in adolescents and young adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute myelogenous leukemia in adolescents and young adults

Published:2018-04-18 Issue:9 Volume:65 Page:e27089
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Creutzig Ursula¹^ORCID,Kutny Matthew A.²^ORCID,Barr Ronald³^ORCID,Schlenk Richard F.⁴,Ribeiro Raul C.⁵

Affiliation:

1. Pediatric Hematology/Oncology; Children's Hospital; Hannover Medical School; Hannover Germany

2. Department of Pediatrics; Division of Hematology/Oncology; University of Alabama at Birmingham; Birmingham Alabama

3. Departments of Pediatrics, Pathology and Medicine; McMaster University; Hamilton Canada

4. National Center for Tumor Diseases (NCT); Heidelberg Germany

5. Department of Hematology/Oncology; St. Jude Children's Research Hospital; Memphis Tennessee

Funder

National Cancer Institute

National Institutes of Health

Cancer Center Support

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference79 articles.

1. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A;Creutzig;Cancer,2008

2. Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia;Kuwatsuka;Int J Hematol,2018

3. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate;Abrahamsson;J Clin Oncol,2011

4. Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004;Creutzig;Blood,2013

5. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531;Gamis;J Clin Oncol,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia;Pediatric Blood & Cancer;2024-08-16

2. Mapping the Grounds for Mortalities in Acute Myeloid Leukemia Through Registry Analyses: A Retrospective Cohort Study of Children, Adolescents, and Young Adults Patients;Journal of Clinical Medicine Research;2024-06

3. Understanding the characteristic behavior of the wild-type and mutant protein structure of FLT3 protein by computational methods;2024-04-21

4. Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients;Journal of Clinical Medicine;2024-04-01

5. Is there scope to do better? Clinical communication with adolescents and young adults with cancer—A scoping review;Psycho-Oncology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3